What is PROCEPT BioRobotics Corp (PRCT)?
PROCEPT BioRobotics Corp is a medical device company specializing in the development and commercialization of robotic systems designed to improve urological procedures. The company's technology focuses on enhancing the precision and efficiency of surgeries related to the treatment of benign prostatic hyperplasia (BPH) and other urological conditions. Its flagship product integrates robotic technology with endoscopic instruments to facilitate minimally invasive procedures, aiming to reduce patient recovery time and improve clinical outcomes. PROCEPT BioRobotics operates within the healthcare sector, collaborating with medical professionals and institutions to advance surgical robotics. The company's research and development efforts are centered on innovation in robotic-assisted surgery, contributing to the broader field of medical robotics. Its operations include regulatory compliance, clinical trials, and partnerships to support the adoption of its technology in healthcare settings. PROCEPT BioRobotics represents a segment of the medical technology industry focused on leveraging robotics to address urological health challenges.
PROCEPT BioRobotics Corp Stock Price Today: Live Overview
The price today is shaped by ongoing trading trends, with PROCEPT BioRobotics Corp currently at $26.14. It has seen prices vary from $25.88 to $26.85, resulting in a daily change of -4.4989%.
FAQ: PROCEPT BioRobotics Corp (PRCT)
What is the current price of PRCT stock?
PROCEPT BioRobotics Corp's current price is $26.14.
Does PRCT pay dividends?
PROCEPT BioRobotics Corp does not pay dividends.
Does PRCT have a formal corporate presence or regional headquarters in the UAE?
PROCEPT BioRobotics Corp operates via partners and distributors and has no official UAE office or subsidiary.
What is PRCT best known for?
PROCEPT BioRobotics Corp is most famous for its robotic surgical systems for urology.
What assets are typically shown together with PRCT?
Commonly shown alongside PRCT: OraSure Technologies Inc, Envista, Friedrich Vorwerk Group SE
Latest shares articles



